264 related articles for article (PubMed ID: 12410169)
1. [Testis cancer markers. Clinical use].
Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
[TBL] [Abstract][Full Text] [Related]
2. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Morris MJ; Bosl GJ
J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
[TBL] [Abstract][Full Text] [Related]
3. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
4. [The role of tumor markers in the treatment of germ cell tumor].
Niwakawa M; Tobisu K
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1159-65. PubMed ID: 11525037
[TBL] [Abstract][Full Text] [Related]
5. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Schatte EC; Lerner SP
J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
[No Abstract] [Full Text] [Related]
6. Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use.
Toner GC
J Clin Oncol; 2004 Oct; 22(19):3842-5. PubMed ID: 15302908
[No Abstract] [Full Text] [Related]
7. [Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis].
Canal P; Villeneuve G; Bugat R; Armand JP; Soula G
Pathol Biol (Paris); 1984 Apr; 32(4):245-50. PubMed ID: 6201806
[TBL] [Abstract][Full Text] [Related]
8. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
Weissbach L; Bussar-Maatz R; Mann K
Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
[TBL] [Abstract][Full Text] [Related]
9. [Significance of serum ferritin level in testicular tumors].
Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
[TBL] [Abstract][Full Text] [Related]
10. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of tumor markers in the treatment of germ cell tumors].
Germá Lluch JR; García del Muro X; Galán MC
Arch Esp Urol; 2000; 53(6):460-8. PubMed ID: 11002513
[TBL] [Abstract][Full Text] [Related]
13. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
[TBL] [Abstract][Full Text] [Related]
14. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
Harland SJ
Br J Urol; 1992 Jun; 69(6):669. PubMed ID: 1379103
[No Abstract] [Full Text] [Related]
15. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
[No Abstract] [Full Text] [Related]
16. Tumor markers in testis cancer.
Klein EA
Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
[TBL] [Abstract][Full Text] [Related]
17. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
18. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
von Eyben FE
Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
[TBL] [Abstract][Full Text] [Related]
20. 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.
Christensen TB; Engbaek F; Marqversen J; Nielsen SI; Kamby C; von der Maase H
Br J Cancer; 1999 Jul; 80(10):1577-81. PubMed ID: 10408402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]